SkinBioTherapeutics had a revenue of 3.06M in the quarter ending Jun 30, 2024, with 94.14%. This bring the company's revenue in the last twelve months to 4.64M, Decreased 73.15%. In the fiscal year ending Jun 30, 2024, SkinBioTherapeutics had annual revenue of 4.64M with 283.63% growth.